Viking Global Investors Lp
Source: SEC Form 13F · as of Mar 2026Viking Global Investors Lp holds 18 biotech & pharma companies tracked by BioSniper, totaling $3.57B in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$3.57B
BioSniper AIPage evidence connected
Prepared research question
What matters most for BridgeBio Pharma, Inc. (BBIO)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| BBIOBridgeBio Pharma, Inc. | 11,842,434 | $879.4M |
| GMOptec International, Inc. | 9,176,943 | $683.7M |
| ADPTAdaptive Biotechnologies Corp | 29,993,708 | $416.3M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 7,062,077 | $398.9M |
| ROIVRoivant Sciences Ltd. | 6,652,448 | $184.3M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 4,203,567 | $134.6M |
| ORKAOruka Therapeutics, Inc. | 2,666,690 | $130.8M |
| SIONSionna Therapeutics, Inc. | 3,195,181 | $128.1M |
| MANEVeradermics Incorporated | 1,690,555 | $106.8M |
| WSTWest Pharmaceutical Services Inc. | 416,948 | $104.5M |
| PHVSPharvaris N.V. | 3,653,310 | $103.2M |
| INBXInhibrx Biosciences, Inc. | 1,437,705 | $96.7M |
| ORICOric Pharmaceuticals, Inc. | 5,824,533 | $73.8M |
| DMRADamora Therapeutics, Inc. | 2,311,082 | $59.9M |
| TRVITrevi Therapeutics, Inc. | 3,198,644 | $38.2M |
| DNAGinkgo Bioworks Holdings Inc. | 3,577,128 | $21.9M |
| PEPGPepGen Inc. | 3,482,434 | $6.2M |
| RLYBRallybio Corp | 524,347 | $4.7M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.